st2825 and Pancreatic-Neoplasms

st2825 has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for st2825 and Pancreatic-Neoplasms

ArticleYear
The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
    Oncology reports, 2023, Volume: 50, Issue:2

    Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; M Phase Cell Cycle Checkpoints; Myeloid Differentiation Factor 88; NF-kappa B; Pancreatic Neoplasms

2023